Donatella Ieluzzi

757 total citations
14 papers, 274 citations indexed

About

Donatella Ieluzzi is a scholar working on Hepatology, Epidemiology and Emergency Medicine. According to data from OpenAlex, Donatella Ieluzzi has authored 14 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 9 papers in Epidemiology and 3 papers in Emergency Medicine. Recurrent topics in Donatella Ieluzzi's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (4 papers). Donatella Ieluzzi is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (4 papers). Donatella Ieluzzi collaborates with scholars based in Italy, Switzerland and United States. Donatella Ieluzzi's co-authors include Giovanna Fattovich, Pierluigi Toniutto, Mario Pirisi, Michela Pasino, Annarosa Cussigh, Carlo Fabris, Elisa Ceriani, Davide Bitetto, Sara Cmet and Edmondo Falleti and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Donatella Ieluzzi

13 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donatella Ieluzzi Italy 8 183 174 100 42 22 14 274
Rika Iwata Switzerland 5 110 0.6× 78 0.4× 77 0.8× 22 0.5× 15 0.7× 6 173
Aymin Delgado‐Borrego United States 8 271 1.5× 279 1.6× 30 0.3× 15 0.4× 26 1.2× 12 363
Steven Young United States 8 117 0.6× 52 0.3× 37 0.4× 27 0.6× 7 0.3× 31 263
Estela Álvarez Argentina 9 379 2.1× 333 1.9× 34 0.3× 10 0.2× 8 0.4× 17 446
Maheeba Abdulla Bahrain 8 143 0.8× 99 0.6× 24 0.2× 9 0.2× 66 3.0× 27 266
Venessa Pattullo Australia 10 260 1.4× 262 1.5× 23 0.2× 3 0.1× 13 0.6× 19 348
Corinne Njapoum France 5 404 2.2× 366 2.1× 131 1.3× 9 0.2× 2 0.1× 6 471
Pilar Cubiles Sánchez-Pobre Spain 8 73 0.4× 70 0.4× 34 0.3× 11 0.3× 5 0.2× 14 214
Carlos Míguez Argentina 8 219 1.2× 254 1.5× 19 0.2× 15 0.4× 20 0.9× 11 321
Bruno Devergie France 7 296 1.6× 305 1.8× 13 0.1× 4 0.1× 16 0.7× 11 351

Countries citing papers authored by Donatella Ieluzzi

Since Specialization
Citations

This map shows the geographic impact of Donatella Ieluzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donatella Ieluzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donatella Ieluzzi more than expected).

Fields of papers citing papers by Donatella Ieluzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donatella Ieluzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donatella Ieluzzi. The network helps show where Donatella Ieluzzi may publish in the future.

Co-authorship network of co-authors of Donatella Ieluzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Donatella Ieluzzi. A scholar is included among the top collaborators of Donatella Ieluzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donatella Ieluzzi. Donatella Ieluzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bevilacqua, Michele, Simone Romano, Filippo Cattazzo, et al.. (2025). Atezolizumab plus Bevacizumab does not cause subclinical cardiotoxicity evaluated by Left-Ventricular Global Longitudinal Strain. Digestive and Liver Disease. 57. S66–S66.
2.
Bevilacqua, Michele, et al.. (2024). Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis. Digestive and Liver Disease. 56(9). 1522–1528. 1 indexed citations
3.
Dalbeni, Andrea, Filippo Cattazzo, Michele Bevilacqua, et al.. (2023). The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study. PLoS ONE. 18(2). e0281813–e0281813. 4 indexed citations
4.
Bevilacqua, Michele, Francesco Dima, Filippo Cattazzo, et al.. (2023). Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia. Internal and Emergency Medicine. 18(5). 1397–1404. 2 indexed citations
5.
Dalbeni, Andrea, Rosanna Villani, Michele Bevilacqua, et al.. (2022). Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience. Journal of Digestive Diseases. 23(5-6). 324–330. 3 indexed citations
6.
Russo, Roberta, Achille Iolascon, Donatella Ieluzzi, et al.. (2015). Protease inhibitors‐based therapy induces acquired spherocytic‐like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients. Liver International. 36(1). 49–58. 8 indexed citations
7.
Lupo, Fabio, Roberta Russo, Achille Iolascon, et al.. (2015). Acquired spherocytic like anemia combined with ineffective erythropoiesis sustains anemia in patients with chronic hepatitis C infection receiving telaprevir or boceprevir-based triple therapy. Digestive and Liver Disease. 47. e15–e15. 1 indexed citations
8.
Martini, Andréa, Giovanna Fattovich, Maria Guido, et al.. (2015). HCV genotype 3 and squamous cell carcinoma antigen (SCCA)‐IgM are independently associated with histological features of NASH in HCV‐infected patients. Journal of Viral Hepatitis. 22(10). 800–808. 10 indexed citations
9.
Ieluzzi, Donatella, Loredana Covolo, Francesco Donato, & Giovanna Fattovich. (2014). Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy. Digestive and Liver Disease. 46(5). 427–432. 24 indexed citations
11.
Falleti, Edmondo, Sara Cmet, Carlo Fabris, et al.. (2013). Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C. PLoS ONE. 8(11). e80764–e80764. 16 indexed citations
12.
Fattovich, Giovanna, Gianluca Svegliati‐Baroni, Michela Pasino, et al.. (2012). Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome. Digestive and Liver Disease. 44(5). 419–425. 9 indexed citations
13.
Falleti, Edmondo, Davide Bitetto, Carlo Fabris, et al.. (2012). Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Hepatology. 56(5). 1641–1650. 55 indexed citations
14.
Bitetto, Davide, Giovanna Fattovich, Carlo Fabris, et al.. (2011). Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology. 53(4). 1118–1126. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026